Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$20.94 - $38.01 $774,780 - $1.41 Million
37,000 New
37,000 $1.32 Million
Q3 2021

Nov 09, 2021

SELL
$98.77 - $132.17 $5.93 Million - $7.93 Million
-60,000 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$109.77 - $165.68 $6.59 Million - $9.94 Million
60,000 New
60,000 $7.45 Million
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $4.45 Million - $6.27 Million
-35,000 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$99.96 - $135.93 $3.5 Million - $4.76 Million
35,000 New
35,000 $4.51 Million
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $8.03 Million - $11.2 Million
-100,000 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$60.49 - $97.5 $6.05 Million - $9.75 Million
100,000 New
100,000 $8.11 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.